2-(3,4-dichlorophenyl)-N-methyl-N-[(1S,2S)-2-(1-pyrrolidinyl)cyclohexyl]acetamide (BioDeep_00000846150)

   


代谢物信息卡片


2-(3,4-dichlorophenyl)-N-methyl-N-[(1S,2S)-2-(1-pyrrolidinyl)cyclohexyl]acetamide

化学式: C19H26Cl2N2O (368.1422086)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CN(C1CCCCC1N2CCCC2)C(=O)CC3=CC(=C(C=C3)Cl)Cl
InChI: InChI=1S/C19H26Cl2N2O/c1-22(19(24)13-14-8-9-15(20)16(21)12-14)17-6-2-3-7-18(17)23-10-4-5-11-23/h8-9,12,17-18H,2-7,10-11,13H2,1H3/t17-,18-/m0/s1

描述信息

同义名列表

1 个代谢物同义名

2-(3,4-dichlorophenyl)-N-methyl-N-[(1S,2S)-2-(1-pyrrolidinyl)cyclohexyl]acetamide



数据库引用编号

4 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Qin Zheng, Qi Wu, Hong Yang, Qiuhong Chen, Xiaohui Li, Jingyi Guo. A κ-OR Agonist Protects the Endothelial Function Impaired by Hyperuricemia Through Regulating the Akt/eNOS Signal Pathway. Probiotics and antimicrobial proteins. 2022 08; 14(4):751-759. doi: 10.1007/s12602-022-09945-1. [PMID: 35536506]
  • Kanako Miyano, Yuki Yoshida, Shigeto Hirayama, Hideki Takahashi, Haruka Ono, Yoshiyuki Meguro, Sei Manabe, Akane Komatsu, Miki Nonaka, Takaaki Mizuguchi, Hideaki Fujii, Yoshikazu Higami, Minoru Narita, Yasuhito Uezono. Oxytocin Is a Positive Allosteric Modulator of κ-Opioid Receptors but Not δ-Opioid Receptors in the G Protein Signaling Pathway. Cells. 2021 10; 10(10):. doi: 10.3390/cells10102651. [PMID: 34685631]
  • Laura L Erwin, Mark R Nilges, Ian B Denys, Jane C Sutphen, Ashton J Friend, Daniel R Kapusta, Peter J Winsauer. Interactive effects of (±)-trans-U50488 and its stereoisomers with cannabinoids. Pharmacology, biochemistry, and behavior. 2021 08; 207(?):173218. doi: 10.1016/j.pbb.2021.173218. [PMID: 34118232]
  • Amelia Dunn, Kyle Windisch, Ariel Ben-Ezra, Phillip Pikus, Michelle Morochnik, Jose Erazo, Brian Reed, Mary Jeanne Kreek. Modulation of cocaine-related behaviors by low doses of the potent KOR agonist nalfurafine in male C57BL6 mice. Psychopharmacology. 2020 Aug; 237(8):2405-2418. doi: 10.1007/s00213-020-05543-7. [PMID: 32435819]
  • Li-Jie Liu, Jian-Jun Yu, Xiao-Lin Xu. Kappa-opioid receptor agonist U50448H protects against renal ischemia-reperfusion injury in rats via activating the PI3K/Akt signaling pathway. Acta pharmacologica Sinica. 2018 Jan; 39(1):97-106. doi: 10.1038/aps.2017.51. [PMID: 28770825]
  • M Morgan, A Heffernan, F Benhabib, S Wagner, A K Hewavitharana, P N Shaw, P J Cabot. The efficacy of Dynorphin fragments at the κ, μ and δ opioid receptor in transfected HEK cells and in an animal model of unilateral peripheral inflammation. Peptides. 2017 03; 89(?):9-16. doi: 10.1016/j.peptides.2016.12.019. [PMID: 28049031]
  • S Michael Owens, Gerald T Pollard, James L Howard, Timothy R Fennell, Rodney W Snyder, F Ivy Carroll. Pharmacodynamic Relationships between Duration of Action of JDTic-like Kappa-Opioid Receptor Antagonists and Their Brain and Plasma Pharmacokinetics in Rats. ACS chemical neuroscience. 2016 12; 7(12):1737-1745. doi: 10.1021/acschemneuro.6b00249. [PMID: 27700049]
  • Juan Li, Xiaojie Liang, Yaguang Zhou, Shumiao Zhang, Fan Yang, Haitao Guo, Rong Fan, Na Feng, Min Jia, Yueming Wang, Mingchao Liu, Jianming Pei. Role of dynorphin in hypoxic pulmonary hypertension. European journal of pharmacology. 2016 Nov; 791(?):78-84. doi: 10.1016/j.ejphar.2016.08.019. [PMID: 27568355]
  • Géza Berecki, Leonid Motin, David J Adams. Mechanism of direct Cav2.2 channel block by the κ-opioid receptor agonist U50488H. Neuropharmacology. 2016 10; 109(?):49-58. doi: 10.1016/j.neuropharm.2016.05.019. [PMID: 27245500]
  • Fei Tian, Xu-Yang Zheng, Juan Li, Shu-Miao Zhang, Na Feng, Hai-Tao Guo, Min Jia, Yue-Min Wang, Rong Fan, Jian-Ming Pei. κ-Opioid Receptor Stimulation Improves Endothelial Function via Akt-stimulated NO Production in Hyperlipidemic Rats. Scientific reports. 2016 05; 6(?):26807. doi: 10.1038/srep26807. [PMID: 27226238]
  • Nicole A Crowley, Daniel W Bloodgood, J Andrew Hardaway, Alexis M Kendra, Jordan G McCall, Ream Al-Hasani, Nora M McCall, Waylin Yu, Zachary L Schools, Michael J Krashes, Bradford B Lowell, Jennifer L Whistler, Michael R Bruchas, Thomas L Kash. Dynorphin Controls the Gain of an Amygdalar Anxiety Circuit. Cell reports. 2016 Mar; 14(12):2774-83. doi: 10.1016/j.celrep.2016.02.069. [PMID: 26997280]
  • Xuan Zhou, Dongjuan Wang, Yuyang Zhang, Jinxia Zhang, Dingcheng Xiang, Haichang Wang. Activation of κ-opioid receptor by U50,488H improves vascular dysfunction in streptozotocin-induced diabetic rats. BMC endocrine disorders. 2015 Feb; 15(?):7. doi: 10.1186/s12902-015-0004-7. [PMID: 25887435]
  • Yulong Shang, Fan Guo, Juan Li, Rong Fan, Xinliang Ma, Yuemin Wang, Na Feng, Yue Yin, Min Jia, Shumiao Zhang, Jingjun Zhou, Hongbing Wang, Jianming Pei. Activation of κ-opioid receptor exerts the glucose-homeostatic effect in streptozotocin-induced diabetic mice. Journal of cellular biochemistry. 2015 Feb; 116(2):252-9. doi: 10.1002/jcb.24962. [PMID: 25186835]
  • Qianmei Wang, Yang Sun, Juan Li, Wenjuan Xing, Shumiao Zhang, Xiaoming Gu, Na Feng, Lei Zhao, Rong Fan, Yuemin Wang, Wen Yin, Jianming Pei. Quaternary ammonium salt of U50488H, a new κ-opioid receptor agonist, protects rat heart against ischemia/reperfusion injury. European journal of pharmacology. 2014 Aug; 737(?):177-84. doi: 10.1016/j.ejphar.2014.05.006. [PMID: 24855042]
  • Shayla E Russell, Anna B Rachlin, Karen L Smith, John Muschamp, Loren Berry, Zhiyang Zhao, Elena H Chartoff. Sex differences in sensitivity to the depressive-like effects of the kappa opioid receptor agonist U-50488 in rats. Biological psychiatry. 2014 Aug; 76(3):213-22. doi: 10.1016/j.biopsych.2013.07.042. [PMID: 24090794]
  • JiaJi Lin, HaiYan Wang, Juan Li, QianMei Wang, ShuMiao Zhang, Na Feng, Rong Fan, JianMing Pei. κ-Opioid receptor stimulation modulates TLR4/NF-κB signaling in the rat heart subjected to ischemia-reperfusion. Cytokine. 2013 Mar; 61(3):842-8. doi: 10.1016/j.cyto.2013.01.002. [PMID: 23402995]
  • Tânia C Chicre-Alcântara, Karla E Torres-Chávez, Luana Fischer, Juliana T Clemente-Napimoga, Vilma Melo, Carlos Amílcar Parada, Claudia Herrera Tambeli. Local kappa opioid receptor activation decreases temporomandibular joint inflammation. Inflammation. 2012 Feb; 35(1):371-6. doi: 10.1007/s10753-011-9329-1. [PMID: 21484425]
  • Xiaodong Wu, Bo Zhang, Rong Fan, Lei Zhao, Yuemin Wang, Shumiao Zhang, Alan David Kaye, Luyu Huang, Jianming Pei. U50,488H inhibits neutrophil accumulation and TNF-α induction induced by ischemia-reperfusion in rat heart. Cytokine. 2011 Nov; 56(2):503-7. doi: 10.1016/j.cyto.2011.07.015. [PMID: 21843951]
  • B A S Reyes, Charles Chavkin, E J Van Bockstaele. Agonist-induced internalization of κ-opioid receptors in noradrenergic neurons of the rat locus coeruleus. Journal of chemical neuroanatomy. 2010 Dec; 40(4):301-9. doi: 10.1016/j.jchemneu.2010.09.003. [PMID: 20884346]
  • Yulin Wang, Wei Xu, Peng Huang, Charles Chavkin, Elisabeth J Van Bockstaele, Lee-Yuan Liu-Chen. Effects of acute agonist treatment on subcellular distribution of kappa opioid receptor in rat spinal cord. Journal of neuroscience research. 2009 May; 87(7):1695-702. doi: 10.1002/jnr.21971. [PMID: 19130621]
  • Fan Rong, Zhang Peng, Ming-Xiang Ye, Quan-Yu Zhang, Yin Zhao, Shu-Miao Zhang, Hai-Tao Guo, Bi Hui, Yue-Min Wang, Cheng Liang, Chun-Hu Gu, Chen Tao, Qin Cui, Shi-Qiang Yu, Ding-Hua Yi, Jian-Ming Pei. Myocardial apoptosis and infarction after ischemia/reperfusion are attenuated by kappa-opioid receptor agonist. Archives of medical research. 2009 May; 40(4):227-34. doi: 10.1016/j.arcmed.2009.04.009. [PMID: 19608010]
  • Craig Bolte, Gilbert Newman, Jo El J Schultz. Hypertensive state, independent of hypertrophy, exhibits an attenuated decrease in systolic function on cardiac kappa-opioid receptor stimulation. American journal of physiology. Heart and circulatory physiology. 2009 Apr; 296(4):H967-75. doi: 10.1152/ajpheart.00909.2008. [PMID: 19181965]
  • Walter Wittmann, Eduard Schunk, Iris Rosskothen, Stefano Gaburro, Nicolas Singewald, Herbert Herzog, Christoph Schwarzer. Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2009 Feb; 34(3):775-85. doi: 10.1038/npp.2008.142. [PMID: 18800067]
  • John E Pascoe, Keith L Williams, Partha Mukhopadhyay, Kenner C Rice, James H Woods, Mei-Chuan Ko. Effects of mu, kappa, and delta opioid receptor agonists on the function of hypothalamic-pituitary-adrenal axis in monkeys. Psychoneuroendocrinology. 2008 May; 33(4):478-86. doi: 10.1016/j.psyneuen.2008.01.006. [PMID: 18325678]
  • Hai-Tao Guo, Rong-Huai Zhang, Lu-Yu Huang, Juan Li, Ya-Li Liu, Hui Bi, Quan Yu Zhang, Yue-Min Wang, Xin Sun, Xin-Liang Ma, Liang Cheng, Jing-Cheng Liu, Shi-Qiang Yu, Ding-Hua Yi, Jian-Ming Pei. Mechanisms involved in the hypotensive effect of a kappa-opioid receptor agonist in hypertensive rats. Archives of medical research. 2007 Oct; 38(7):723-9. doi: 10.1016/j.arcmed.2007.04.009. [PMID: 17845890]
  • Liang Cheng, Sai Ma, Long-Xiao Wei, Hai-Tao Guo, Lu-Yu Huang, Hui Bi, Rong Fan, Juan Li, Ya-Li Liu, Yue-Min Wang, Xin Sun, Quan-Yu Zhang, Shi-Qiang Yu, Ding-Hua Yi, Xin-Liang Ma, Jian-Ming Pei. Cardioprotective and antiarrhythmic effect of U50,488H in ischemia/reperfusion rat heart. Heart and vessels. 2007 Sep; 22(5):335-44. doi: 10.1007/s00380-007-0983-z. [PMID: 17879026]
  • Wei Qi, K Kumar Ebenezar, Mohamed A Samhan, Francine G Smith. Renal responses to the kappa-opioid-receptor agonist U-50488H in conscious lambs. American journal of physiology. Regulatory, integrative and comparative physiology. 2007 Jul; 293(1):R162-8. doi: 10.1152/ajpregu.00863.2006. [PMID: 17409260]
  • Wei Qi, Francine G Smith. Modulation of systemic and renal haemodynamics by kappa-opioids in conscious lambs. Experimental physiology. 2006 Sep; 91(5):877-85. doi: 10.1113/expphysiol.2006.033456. [PMID: 16728455]
  • Jay P McLaughlin, Benjamin B Land, Shuang Li, John E Pintar, Charles Chavkin. Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2006 Apr; 31(4):787-94. doi: 10.1038/sj.npp.1300860. [PMID: 16123754]
  • Chongguang Chen, Jian-Guo Li, Yong Chen, Peng Huang, Yulin Wang, Lee-Yuan Liu-Chen. GEC1 interacts with the kappa opioid receptor and enhances expression of the receptor. The Journal of biological chemistry. 2006 Mar; 281(12):7983-93. doi: 10.1074/jbc.m509805200. [PMID: 16431922]
  • Eva Maria Marco, Ricardo Llorente, Laura Pérez-Alvarez, Enrique Moreno, Carmen Guaza, Maria Paz Viveros. The kappa-opioid receptor is involved in the stimulating effect of nicotine on adrenocortical activity but not in nicotine induced anxiety. Behavioural brain research. 2005 Sep; 163(2):212-8. doi: 10.1016/j.bbr.2005.05.005. [PMID: 15979169]
  • Eddy H T Wu, Yung H Wong. Activation of delta-, kappa-, and mu-opioid receptors induces phosphorylation of tuberin in transfected HEK 293 cells and native cells. Biochemical and biophysical research communications. 2005 Sep; 334(3):838-44. doi: 10.1016/j.bbrc.2005.06.184. [PMID: 16053916]
  • Asunción Romero, Eulalia Planas, Raquel Poveda, Silvia Sánchez, Olga Pol, Margarita M Puig. Anti-exudative effects of opioid receptor agonists in a rat model of carrageenan-induced acute inflammation of the paw. European journal of pharmacology. 2005 Mar; 511(2-3):207-17. doi: 10.1016/j.ejphar.2005.02.004. [PMID: 15792790]
  • Shiou-Lan Chen, Eagle Yi-Kung Huang, Lok-Hi Chow, Pao-Luh Tao. Dextromethorphan differentially affects opioid antinociception in rats. British journal of pharmacology. 2005 Feb; 144(3):400-4. doi: 10.1038/sj.bjp.0706086. [PMID: 15655510]
  • Helmut B Gottlieb, Kurt J Varner, Velga A Kenigs, Antonio M Cabral, Daniel R Kapusta. Differential cardiovascular and renal responses produced by microinjection of the {kappa}-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus. The Journal of pharmacology and experimental therapeutics. 2005 Feb; 312(2):678-85. doi: 10.1124/jpet.104.076828. [PMID: 15381735]
  • Juliana T Clemente, Carlos A Parada, Maria C Arruda Veiga, Robert W Gear, Cláudia H Tambeli. Sexual dimorphism in the antinociception mediated by kappa opioid receptors in the rat temporomandibular joint. Neuroscience letters. 2004 Dec; 372(3):250-5. doi: 10.1016/j.neulet.2004.09.048. [PMID: 15542250]
  • Guijun Wang, Hongxin Wang, Yanling Yang, Tak Ming Wong. Kappa-opioid receptor stimulation inhibits growth of neonatal rat ventricular myocytes. European journal of pharmacology. 2004 Sep; 498(1-3):53-8. doi: 10.1016/j.ejphar.2004.07.082. [PMID: 15363975]
  • Magdalena Chadzinska, Barbara Plytycz. Differential migratory properties of mouse, fish, and frog leukocytes treated with agonists of opioid receptors. Developmental and comparative immunology. 2004 Jul; 28(9):949-58. doi: 10.1016/j.dci.2004.02.003. [PMID: 15183035]
  • Peng Huang, Deborah Steplock, Edward J Weinman, Randy A Hall, Zhe Ding, Jianguo Li, Yulin Wang, Lee-Yuan Liu-Chen. kappa Opioid receptor interacts with Na(+)/H(+)-exchanger regulatory factor-1/Ezrin-radixin-moesin-binding phosphoprotein-50 (NHERF-1/EBP50) to stimulate Na(+)/H(+) exchange independent of G(i)/G(o) proteins. The Journal of biological chemistry. 2004 Jun; 279(24):25002-9. doi: 10.1074/jbc.m313366200. [PMID: 15070904]
  • M Soaje, R P Deis. Involvement of opioid receptor subtypes in both stimulatory and inhibitory effects of the opioid peptides on prolactin secretion during pregnancy. Cellular and molecular neurobiology. 2004 Apr; 24(2):193-204. doi: 10.1023/b:cemn.0000018616.00018.98. [PMID: 15176435]
  • Selim Kutlu, Bayram Yilmaz, Sinan Canpolat, Suleyman Sandal, Mete Ozcan, Selahattin Kumru, Haluk Kelestimur. Mu opioid modulation of oxytocin secretion in late pregnant and parturient rats. Involvement of noradrenergic neurotransmission. Neuroendocrinology. 2004; 79(4):197-203. doi: 10.1159/000078101. [PMID: 15153753]
  • M C H Ko, K J Willmont, H Lee, G S Flory, J H Woods. Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys. Brain research. 2003 Aug; 982(1):38-44. doi: 10.1016/s0006-8993(03)02938-x. [PMID: 12915238]
  • R Wood, L Eichel, E M Messing, E Schwarz. Automated noninvasive measurement of cyclophosphamide-induced changes in murine micturition frequency and volume and demonstration of pharmacologic sensitivity. Urology. 2001 Jun; 57(6 Suppl 1):115-6. doi: 10.1016/s0090-4295(01)01059-7. [PMID: 11378091]
  • D C Brown, S Z Perkowski, F Shofer, J A Amico. Effect of centrally administered opioid receptor agonists on CSF and plasma oxytocin concentrations in dogs. American journal of veterinary research. 2001 Apr; 62(4):496-9. doi: 10.2460/ajvr.2001.62.496. [PMID: 11327454]
  • S Kumru, M Simşek, B Yilmaz, E Sapmaz, S Kutlu, S Sandal, S Canpolat. Differential regulation of preovulatory luteinizing hormone and follicle-stimulating hormone release by opioids in the proestrous rat. Physiological research. 2001; 50(4):397-403. doi: NULL. [PMID: 11551146]
  • A R Dehpour, H Rastegar, M Jorjani, F Roushanzamir, K Joharchi, A Ahmadiani. Subsensitivity to opioids is receptor-specific in isolated guinea pig ileum and mouse vas deferens after obstructive cholestasis. The Journal of pharmacology and experimental therapeutics. 2000 Jun; 293(3):946-51. doi: NULL. [PMID: 10869396]
  • J M Gschossmann, V V Chaban, J A McRoberts, H E Raybould, S H Young, H S Ennes, T Lembo, E A Mayer. Mechanical activation of dorsal root ganglion cells in vitro: comparison with capsaicin and modulation by kappa-opioids. Brain research. 2000 Feb; 856(1-2):101-10. doi: 10.1016/s0006-8993(99)02353-7. [PMID: 10677616]
  • C Zubaran, M Shoaib, I P Stolerman, J Pablo, D C Mash. Noribogaine generalization to the ibogaine stimulus: correlation with noribogaine concentration in rat brain. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 1999 Jul; 21(1):119-26. doi: 10.1016/s0893-133x(99)00003-2. [PMID: 10379526]
  • M L Laorden, M V Milanés. Effects of morphine and U-50,488H on neurochemical activity of the hypothalamic noradrenergic neurons and pituitary-adrenal response. Neuropeptides. 1999 Apr; 33(2):131-5. doi: 10.1054/npep.1999.0007. [PMID: 10657482]
  • S F Sezen, V A Kenigs, D R Kapusta. Renal excretory responses produced by the delta opioid agonist, BW373U86, in conscious rats. The Journal of pharmacology and experimental therapeutics. 1998 Oct; 287(1):238-45. doi: NULL. [PMID: 9765343]
  • A M Cabral, K J Varner, D R Kapusta. Renal excretory responses produced by central administration of opioid agonists in ketamine and xylazine-anesthetized rats. The Journal of pharmacology and experimental therapeutics. 1997 Aug; 282(2):609-16. doi: NULL. [PMID: 9262322]
  • C Guéniau, C Oberlander. The kappa opioid agonist niravoline decreases brain edema in the mouse middle cerebral artery occlusion model of stroke. The Journal of pharmacology and experimental therapeutics. 1997 Jul; 282(1):1-6. doi: NULL. [PMID: 9223533]
  • A D Blake, G Bot, S Li, J C Freeman, T Reisine. Differential agonist regulation of the human kappa-opioid receptor. Journal of neurochemistry. 1997 May; 68(5):1846-52. doi: 10.1046/j.1471-4159.1997.68051846.x. [PMID: 9109509]
  • C C Taylor, D Wu, Y Soong, J S Yee, H H Szeto. Opioid modulation of the fetal hypothalamic-pituitary-adrenal axis: the role of receptor subtypes and route of administration. The Journal of pharmacology and experimental therapeutics. 1997 Apr; 281(1):129-35. doi: NULL. [PMID: 9103489]
  • P L Tao, W C Liu, Y S Tsuei, C Y Cheng. The role of vasopressin on the effect of U-50,488 to block the development of morphine tolerance and physical dependence. Naunyn-Schmiedeberg's archives of pharmacology. 1997 Feb; 355(2):281-7. doi: 10.1007/pl00004944. [PMID: 9050024]
  • C C Taylor, D Wu, Y Soong, J S Yee, H H Szeto. Dynorphin A1-13 stimulates ovine fetal pituitary-adrenal function through a novel nonopioid mechanism. The Journal of pharmacology and experimental therapeutics. 1997 Jan; 280(1):416-21. doi: NULL. [PMID: 8996223]
  • C C Taylor, D WU, Y Soong, J S Yee, H H Szeto. Differential mechanisms of ovine fetal pituitary stimulation by a selective kappa-opioid agonist and by dynorphin. Neuroendocrinology. 1996 Dec; 64(6):419-24. doi: 10.1159/000127147. [PMID: 8990074]
  • J P Walsh, I J Clarke. Effects of central administration of highly selective opioid mu-, delta- and kappa-receptor agonists on plasma luteinizing hormone (LH), prolactin, and the estrogen-induced LH surge in ovariectomized ewes. Endocrinology. 1996 Sep; 137(9):3640-8. doi: 10.1210/endo.137.9.8756528. [PMID: 8756528]
  • C C Taylor, D Wu, Y Soong, J S Yee, H H Szeto. kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor. The Journal of pharmacology and experimental therapeutics. 1996 May; 277(2):877-84. doi: NULL. [PMID: 8627570]
  • L O Ebbesson, P Deviche, S O Ebbesson. Distribution and changes in mu- and kappa-opiate receptors during the midlife neurodevelopmental period of Coho salmon, Oncorhynchus kisutch. The Journal of comparative neurology. 1996 Mar; 366(3):448-64. doi: 10.1002/(sici)1096-9861(19960311)366:3<448::aid-cne6>3.0.co;2-4. [PMID: 8907358]
  • D R Kapusta, J C Obih. Central kappa opioids blunt the renal excretory responses to volume expansion by a renal nerve-dependent mechanism. The Journal of pharmacology and experimental therapeutics. 1995 Apr; 273(1):199-205. doi: NULL. [PMID: 7714767]
  • A K Di, L Huang. [Effect of U-50, 488H administered centrally in rats on urination and activity of TH-IR neurons in PVH]. Sheng li xue bao : [Acta physiologica Sinica]. 1995 Apr; 47(2):187-94. doi: NULL. [PMID: 7652595]
  • M V Milanés, M L Vargas, M I Martín. Involvement of kappa-opioid receptor mechanisms in the calcitonin-induced potentiation of opioid effects at the hypothalamus-pituitary-adrenocortical axis. European journal of pharmacology. 1994 Dec; 271(1):103-9. doi: 10.1016/0014-2999(94)90270-4. [PMID: 7698193]
  • P M Bull, A J Douglas, J A Russell. Opioids and coupling of the anterior peri-third ventricular input to oxytocin neurones in anaesthetized pregnant rats. Journal of neuroendocrinology. 1994 Jun; 6(3):267-74. doi: 10.1111/j.1365-2826.1994.tb00582.x. [PMID: 7920592]
  • P Nencini, P Valeri. The role of opioid mechanisms in the anorectic effects of stimulants: U50,488H enhances amphetamine inhibition of free feeding in rats. Pharmacology, biochemistry, and behavior. 1994 May; 48(1):63-8. doi: 10.1016/0091-3057(94)90499-5. [PMID: 7913232]
  • H N Bhargava, G A Matwyshyn, A K Rattan, K L Koo, G A Tejwani. beta-Endorphin-like immunoreactivity in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and -abstinent rats. The Journal of pharmacology and experimental therapeutics. 1994 Feb; 268(2):856-61. doi: NULL. [PMID: 8113998]
  • Y Iwasaki, M B Gaskill, C A Boss, G L Robertson. The effect of the nonselective opioid antagonist diprenorphine on vasopressin secretion in the rat. Endocrinology. 1994 Jan; 134(1):48-54. doi: 10.1210/endo.134.1.8275962. [PMID: 8275962]
  • H Tsushima, M Mori, T Matsuda. Microinjection of dynorphin into the supraoptic and paraventricular nuclei produces antidiuretic effects through vasopressin release. Japanese journal of pharmacology. 1993 Dec; 63(4):461-8. doi: 10.1254/jjp.63.461. [PMID: 7907154]
  • D R Kapusta, J C Obih. Central kappa opioid receptor-evoked changes in renal function in conscious rats: participation of renal nerves. The Journal of pharmacology and experimental therapeutics. 1993 Oct; 267(1):197-204. doi: NULL. [PMID: 8229746]
  • C Alcaraz, M V Milanés, M L Vargas. Chronic kappa opioid receptor antagonism produces supersensitivity to U-50,488H at the hypothalamo-pituitary-adrenocortical (HPA) axis level. The Journal of pharmacology and experimental therapeutics. 1993 Sep; 266(3):1385-9. doi: NULL. [PMID: 8396634]
  • C Alcaraz, M L Vargas, T Fuente, M V Milanés. Chronic naloxone treatment induces supersensitivity to a mu but not to a kappa agonist at the hypothalamus-pituitary-adrenocortical axis level. The Journal of pharmacology and experimental therapeutics. 1993 Sep; 266(3):1602-6. doi: NULL. [PMID: 8396640]
  • A J Douglas, S Dye, G Leng, J A Russell, R J Bicknell. Endogenous opioid regulation of oxytocin secretion through pregnancy in the rat. Journal of neuroendocrinology. 1993 Jun; 5(3):307-14. doi: 10.1111/j.1365-2826.1993.tb00487.x. [PMID: 8100468]
  • A J Douglas, G Clarke, S J MacMillan, P M Bull, I Neumann, S A Way, D M Wright, B G McGrory, J A Russell. Effects of the kappa-opioid agonist U50,488 on parturition in rats. British journal of pharmacology. 1993 May; 109(1):251-8. doi: 10.1111/j.1476-5381.1993.tb13561.x. [PMID: 8388299]
  • H N Bhargava, G A Matwyshyn, A K Rattan, K L Koo, G A Tejwani. The effect of U-50,488H tolerance-dependence and abstinence on the levels of dynorphin (1-13) in brain regions, spinal cord, pituitary gland and peripheral tissues of the rat. Brain research. 1993 Jan; 600(1):151-5. doi: 10.1016/0006-8993(93)90413-h. [PMID: 8093675]
  • A Petit, N Gallo-Payet, D Bellabarba, J G Lehoux, S Bélisle. The modulation of placental lactogen release by opioids: a role for extracellular calcium. Molecular and cellular endocrinology. 1993 Jan; 90(2):165-70. doi: 10.1016/0303-7207(93)90148-d. [PMID: 7684340]
  • J Manzanares, E J Wagner, K E Moore, K J Lookingland. Kappa opioid receptor-mediated regulation of prolactin and alpha-melanocyte-stimulating hormone secretion in male and female rats. Life sciences. 1993; 53(10):795-801. doi: 10.1016/0024-3205(93)90501-s. [PMID: 8394964]
  • K M Pumford, J A Russell, G Leng. Effects of the selective kappa-opioid agonist U50,488 upon the electrical activity of supraoptic neurones in morphine-tolerant and morphine-naive rats. Experimental brain research. 1993; 94(2):237-46. doi: 10.1007/bf00230291. [PMID: 8395406]
  • M Gavend, M Mallaret, F Caron, G Baragatti. Antagonism of metergoline on the diuretic effect of cyclazocine and U-50488 drugs with a kappa agonist activity. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 1993; 47(8):337-44. doi: 10.1016/0753-3322(93)90083-w. [PMID: 8061255]
  • W Jin, N M Lee, H H Loh, S A Thayer. Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma x glioma hybrid NG108-15 cells. Molecular pharmacology. 1992 Dec; 42(6):1083-9. doi: . [PMID: 1336113]
  • M D Lee, P G Clifton. Free-feeding and free-drinking patterns of male rats following treatment with opiate kappa agonists. Physiology & behavior. 1992 Dec; 52(6):1179-85. doi: 10.1016/0031-9384(92)90479-l. [PMID: 1336603]
  • P G Green, J D Levine. Delta- and kappa-opioid agonists inhibit plasma extravasation induced by bradykinin in the knee joint of the rat. Neuroscience. 1992 Jul; 49(1):129-33. doi: 10.1016/0306-4522(92)90080-l. [PMID: 1328929]
  • L Zhang, Z F Gu, T Pradhan, R T Jensen, P N Maton. Characterization of opioid receptors on smooth muscle cells from guinea pig stomach. The American journal of physiology. 1992 Mar; 262(3 Pt 1):G461-9. doi: 10.1152/ajpgi.1992.262.3.g461. [PMID: 1312793]
  • D M Ignar, R T Windh, C M Kuhn. Chronic administration of U50,488H fails to produce hypothalamo-pituitary-adrenal axis tolerance in neonatal rats. Neuropharmacology. 1992 Feb; 31(2):143-8. doi: 10.1016/0028-3908(92)90024-j. [PMID: 1553027]
  • R M Craft, L A Dykstra. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output. The Journal of pharmacology and experimental therapeutics. 1992 Jan; 260(1):327-33. doi: . [PMID: 1309876]
  • M V Milanés, M L Gonzalvez, T Fuente, M L Vargas. Pituitary-adrenocortical response to acute and chronic administration of U-50,488H in the rat. Neuropeptides. 1991 Oct; 20(2):95-102. doi: 10.1016/0143-4179(91)90058-q. [PMID: 1665898]
  • B S Silbert, A W Lipkowski, M S Cepeda, S K Szyfelbein, P F Osgood, D B Carr. Enhanced potency of receptor-selective opioids after acute burn injury. Anesthesia and analgesia. 1991 Oct; 73(4):427-33. doi: 10.1213/00000539-199110000-00011. [PMID: 1897768]
  • T Wells, M L Forsling. Kappa-opioid modulation of vasopressin secretion in conscious rats. The Journal of endocrinology. 1991 Jun; 129(3):411-6. doi: 10.1677/joe.0.1290411. [PMID: 1648591]
  • G Bianchi. Antidiuretic effect of bremazocine and U-50,488 in rats after alpha 2-adrenoceptor blockade. The Journal of pharmacy and pharmacology. 1991 Mar; 43(3):212-6. doi: 10.1111/j.2042-7158.1991.tb06670.x. [PMID: 1675283]
  • D B Vaupel, E J Cone. Pharmacodynamic and pharmacokinetic actions of ketocyclazocine enantiomers in the dog: absence of sigma- or phencyclidine-like activity. The Journal of pharmacology and experimental therapeutics. 1991 Jan; 256(1):211-21. doi: NULL. [PMID: 1846414]
  • J Haley, S Ketchum, A Dickenson. Peripheral kappa-opioid modulation of the formalin response: an electrophysiological study in the rat. European journal of pharmacology. 1990 Dec; 191(3):437-46. doi: 10.1016/0014-2999(90)94178-z. [PMID: 1964910]
  • D M Ignar, C M Kuhn. Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat. The Journal of pharmacology and experimental therapeutics. 1990 Dec; 255(3):1287-95. doi: . [PMID: 2175800]
  • X Z Khawaja, I C Green, J R Thorpe, C J Bailey. Increased sensitivity to insulin-releasing and glucoregulatory effects of dynorphin A1-13 and U 50488h in ob/ob versus lean mice. Diabetes. 1990 Oct; 39(10):1289-97. doi: 10.2337/diab.39.10.1289. [PMID: 1976559]
  • J Manzanares, K J Lookingland, K E Moore. Kappa-opioid-receptor-mediated regulation of alpha-melanocyte-stimulating hormone secretion and tuberohypophyseal dopaminergic neuronal activity. Neuroendocrinology. 1990 Aug; 52(2):200-5. doi: 10.1159/000125582. [PMID: 2177159]
  • B R de Costa, R B Rothman, V Bykov, L Band, A Pert, A E Jacobson, K C Rice. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands. Journal of medicinal chemistry. 1990 Apr; 33(4):1171-6. doi: 10.1021/jm00166a014. [PMID: 2157008]
  • G Hamon, S Jouquey. Kappa agonists and vasopressin secretion. Hormone research. 1990; 34(3-4):129-32. doi: 10.1159/000181811. [PMID: 1966562]
  • B E Sumner, J E Coombes, K M Pumford, J A Russell. Opioid receptor subtypes in the supraoptic nucleus and posterior pituitary gland of morphine-tolerant rats. Neuroscience. 1990; 37(3):635-45. doi: 10.1016/0306-4522(90)90095-l. [PMID: 2174133]
  • D B Vaupel, E J Cone, R E Johnson, T P Su. Kappa opioid partial agonist activity of the enkephalin-like pentapeptide BW942C based on urination and in vitro studies in humans and animals. The Journal of pharmacology and experimental therapeutics. 1990 Jan; 252(1):225-34. doi: NULL. [PMID: 2153801]
  • N Ashton, R J Balment, T P Blackburn. Kappa-opioid-receptor agonists modulate the renal excretion of water and electrolytes in anaesthetized rats. British journal of pharmacology. 1990 Jan; 99(1):181-5. doi: 10.1111/j.1476-5381.1990.tb14674.x. [PMID: 2158834]
  • M Gué, M Alvinerie, J L Junien, L Buéno. Stimulation of kappa opiate receptors in intestinal wall affects stress-induced increase of plasma cortisol in dogs. Brain research. 1989 Nov; 502(1):143-8. doi: 10.1016/0006-8993(89)90469-1. [PMID: 2555024]